Thyroid Cancer

Latest News

Phase 1 data show that EMI-137 enabled MFGI and spectroscopy differentiation between papillary thyroid cancer–afflicted tissue and healthy thyroid tissue.
MET-Targeted MFGI, Spectroscopy May Detect Papillary Thyroid Cancer

July 18th 2024

Phase 1 data show that EMI-137 enabled MFGI and spectroscopy differentiation between papillary thyroid cancer–afflicted tissue and healthy thyroid tissue.

Retrospective results found considering conservative initial surgery options can reduce overtreatment for patients with thyroid cancer.
Limiting Complete Thyroidectomy Post Hemithyroidectomy, Total Thyroidectomy May Reduce Overtreatment in Thyroid Cancer

July 16th 2024

Phase 3 results show that treatment with vandetanib had no statistically significant improvement in PFS and more adverse effects than placebo.
Vandetanib Does Not Meet PFS End Point for Advanced RAI-Refractory DTC

July 16th 2024

Results from the phase 2b TACTI-003 trial show that eftilagimod alfa plus pembrolizumab achieved high objective response and disease control rates.
Eftilagimod Alfa Combo Appears Efficacious in Head and Neck Cancer

July 12th 2024

As the practice of radiation therapy evolves in HPV-associated OPSCC, updated evidence-based ASTRO guidelines may help inform clinical practices.
ASTRO Updates Guidelines for Radiation Therapy in HPV-Associated OPSCC

June 21st 2024

Video Series
Video Interviews
Podcasts

More News